Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

MYGN

MYRIAD GENETICS INC

CIK 0000899923 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$6.10
↑ 0.23 (3.92%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$576.13M
P/E Ratio
-1.44
EPS
-3.95
Dividend Yield
Not covered
52W Position
51%
Beta
1.33

Valuation multiples

Fwd P/E
46.08
PEG
1.24
P/B
1.71
P/S
0.70
EV/Revenue
0.69
ROE
-118.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 51%
$3.53$8.59

Latest Financials

2025-12-31 FY
Revenue
$824.50M
Net Income
-$365.90M
Total Assets
$706.60M
Free Cash Flow
–

Recent news